Publication:
A case series on the use of atypical long acting injectables as first-line antipsychotic treatment : Who benefits and how?

Simple item page
dc.contributor.authorJaafar, NRNen_US
dc.contributor.authorZakaria, Hen_US
dc.contributor.authorMidin, Men_US
dc.contributor.authorYs, Cen_US
dc.date.accessioned2024-05-29T02:50:45Z
dc.date.available2024-05-29T02:50:45Z
dc.date.issued2012
dc.identifier.epage59
dc.identifier.issn1461-1457
dc.identifier.scopusWOS:000209062500214
dc.identifier.spage59
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/11108
dc.identifier.volume15
dc.languageEnglish
dc.language.isoen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofInternational Journal Of Neuropsychopharmacology
dc.sourceWeb Of Science (ISI)
dc.titleA case series on the use of atypical long acting injectables as first-line antipsychotic treatment : Who benefits and how?
dc.typeMeeting Abstracten_US
dspace.entity.typePublication

Files

Collections

Web of Science_WoS